Journal of the American Society of Nephrology, Vol 6, 121-125, Copyright © 1995 by American Society of Nephrology

REGULAR ARTICLES

Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients

J Bachmann, M Tepel, H Raidt, R Riezler, U Graefe, K Langer and W Zidek
Medizinische Poliklinik, University of Munster, Germany.

The objective of this study was to examine if hyperhomocysteinemia is associated with occlusive vascular disease in hemodialysis patients. The study design included risk factor analysis and determination of serum homocysteine in hemodialysis patients. Fifty chronic uremic patients on regular hemodialysis treatment were studied. Twenty-four patients had coronary, cerebral, or peripheral signs of occlusive vascular disease. Cerebral vascular disease was diagnosed by computed tomography, arterial angiography, or Doppler sonography of the carotid and vertebral arteries. Coronary vascular disease was diagnosed by documented history of myocardial infarction or by coronary angiography. The diagnosis of peripheral vascular disease was established by angiography of the lower limb arteries. In all control patients, Doppler sonography of the carotid, vertebral, and lower limb arteries and thallium-201 exercise imaging were without pathologic results. Measurements included blood pressure, body mass index, smoking behavior, serum homocysteine (measured by gas chromatography/mass spectrometry), serum total, low-density lipoprotein, and high-density lipoprotein cholesterol, lipoprotein (a), triglycerides, and plasma fibrinogen. In a stepwise multiple logistic regression analysis, high serum homocysteine was significantly associated with occlusive arterial disease (R = 0.23; P = 0.031). Furthermore, hypertension (R = 0.18; P = 0.058), but not serum total, low-density lipoprotein, and high-density lipoprotein cholesterol, lipoprotein (a), triglycerides, diabetes mellitus, body mass index, plasma fibrinogen, and smoking behavior, was significantly associated with atherosclerosis. Our results support the hypothesis that hyperhomocysteinemia is an independent risk factor for vascular disease in hemodialysis patients.

This article has been cited by other articles:

				J. D Kopple The phenomenon of altered risk factor patterns or reverse epidemiology in persons with advanced chronic kidney failure Am. J. Clinical Nutrition, June 1, 2005; 81(6): 1257 - 1266. [Abstract] [Full Text] [PDF]

				M. E. Suliman, P. Barany, K. Kalantar-Zadeh, B. Lindholm, and P. Stenvinkel Homocysteine in uraemia--a puzzling and conflicting story Nephrol. Dial. Transplant., January 1, 2005; 20(1): 16 - 21. [Full Text] [PDF]

				K. Kalantar-Zadeh, G. Block, M. H. Humphreys, C. J. McAllister, and J. D. Kopple A Low, Rather than a High, Total Plasma Homocysteine Is an Indicator of Poor Outcome in Hemodialysis Patients J. Am. Soc. Nephrol., February 1, 2004; 15(2): 442 - 453. [Abstract] [Full Text] [PDF]

				A. Scholze, C. Rinder, J. Beige, R. Riezler, W. Zidek, and M. Tepel Acetylcysteine Reduces Plasma Homocysteine Concentration and Improves Pulse Pressure and Endothelial Function in Patients With End-Stage Renal Failure Circulation, January 27, 2004; 109(3): 369 - 374. [Abstract] [Full Text] [PDF]

				F. Kronenberg, E. Kuen, E. Ritz, P. Konig, G. Kraatz, K. Lhotta, J. F. E. Mann, G. A. Muller, U. Neyer, W. Riegel, et al. Apolipoprotein A-IV Serum Concentrations Are Elevated in Patients with Mild and Moderate Renal Failure J. Am. Soc. Nephrol., February 1, 2002; 13(2): 461 - 469. [Abstract] [Full Text] [PDF]

				A. O'Hare and K. Johansen Lower-Extremity Peripheral Arterial Disease among Patients with End-Stage Renal Disease J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2838 - 2847. [Abstract] [Full Text] [PDF]

				O. Aras, M. Y. Tsai, N. Q. Hanson, R. Bailey, G. Rao, and D. B. Hunninghake Cystatin C Is an Independent Predictor of Fasting and Post-Methionine Load Total Homocysteine Concentrations among Stable Renal Transplant Recipients Clin. Chem., July 1, 2001; 47(7): 1263 - 1268. [Abstract] [Full Text] [PDF]

				G. SUNDER-PLASSMANN, M. FÖDINGER, H. BUCHMAYER, M. PAPAGIANNOPOULOS, J. WOJCIK, J. KLETZMAYR, B. ENZENBERGER, O. JANATA, W. C. WINKELMAYER, G. PAUL, et al. Effect of High Dose Folic Acid Therapy on Hyperhomocysteinemia in Hemodialysis Patients: Results of the Vienna Multicenter Study J. Am. Soc. Nephrol., June 1, 2000; 11(6): 1106 - 1116. [Abstract] [Full Text]

				H. KIMURA, F. GEJYO, S. SUZUKI, and R. MIYAZAKI The C677T Methylenetetrahydrofolate Reductase Gene Mutation in Hemodialysis Patients J. Am. Soc. Nephrol., May 1, 2000; 11(5): 885 - 893. [Abstract] [Full Text]

				R. Wever, P. Boer, M. Hijmering, E. Stroes, M. Verhaar, J. Kastelein, K. Versluis, F. Lagerwerf, H. van Rijn, H. Koomans, et al. Nitric Oxide Production Is Reduced in Patients With Chronic Renal Failure Arterioscler. Thromb. Vasc. Biol., May 1, 1999; 19(5): 1168 - 1172. [Abstract] [Full Text] [PDF]

				A. G. BOSTOM and B. F. CULLETON Hyperhomocysteinemia in Chronic Renal Disease J. Am. Soc. Nephrol., April 1, 1999; 10(4): 891 - 900. [Full Text]

				M. R. Malinow, A. G. Bostom, and R. M. Krauss Homocyst(e)ine, Diet, and Cardiovascular Diseases : A Statement for Healthcare Professionals From the Nutrition Committee, American Heart Association Circulation, January 12, 1999; 99(1): 178 - 182. [Full Text] [PDF]

				P. S. Dovgan, A. D. Shepard, and T. J. Nypaver Critical Limb Ischemia in Patients with End-Stage Renal Disease: Do Long-Term Results Justify An Aggressive Surgical Approach? Perspectives in Vascular Surgery and Endovascular Therapy, January 1, 1999; 12(1): 81 - 92. [Abstract] [PDF]

				S. C. Tyagi Homocysteine redox receptor and regulation of extracellular matrix components in vascular cells Am J Physiol Cell Physiol, February 1, 1998; 274(2): C396 - C405. [Abstract] [Full Text] [PDF]

				A. Moustapha, A. Naso, M. Nahlawi, A. Gupta, K. L. Arheart, D. W. Jacobsen, K. Robinson, and V. W. Dennis Prospective Study of Hyperhomocysteinemia as an Adverse Cardiovascular Risk Factor in End-Stage Renal Disease Circulation, January 20, 1998; 97(2): 138 - 141. [Abstract] [Full Text] [PDF]

				A. G. Bostom, D. Shemin, P. Verhoef, M. R. Nadeau, P. F. Jacques, J. Selhub, L. Dworkin, and I. H. Rosenberg Elevated Fasting Total Plasma Homocysteine Levels and Cardiovascular Disease Outcomes in Maintenance Dialysis Patients : A Prospective Study Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2554 - 2558. [Abstract] [Full Text]

				A. G. Bostom, R. Y. Gohh, M. Y. Tsai, B. J. Hopkins-Garcia, M. R. Nadeau, L. A. Bianchi, P. F. Jacques, I. H. Rosenberg, and J. Selhub Excess Prevalence of Fasting and Postmethionine-Loading Hyperhomocysteinemia in Stable Renal Transplant Recipients Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 1894 - 1900. [Abstract] [Full Text]

				K. Robinson, A. Gupta, V. Dennis, K. Arheart, D. Chaudhary, R. Green, P. Vigo, E. L. Mayer, J. Selhub, M. Kutner, et al. Hyperhomocysteinemia Confers an Independent Increased Risk of Atherosclerosis in End-Stage Renal Disease and Is Closely Linked to Plasma Folate and Pyridoxine Concentrations Circulation, December 1, 1996; 94(11): 2743 - 2748. [Abstract] [Full Text]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673